DL-Panthenol Encyclopedia — Scientific Background

What Is DL-Panthenol?

DL-Panthenol (CAS 16485-10-2), also known as DL-pantothenol, DL-pantothenyl alcohol, or (±)-α,γ-dihydroxy-N-(3-hydroxypropyl)-β,β-dimethylbutyramide, is the racemic mixture of D- and L-panthenol, the alcohol analog of pantothenic acid (vitamin B5). It is chemically characterized by the molecular formula C₉H₁₉NO₄ and a molecular weight of 205.25 g/mol. DL-Panthenol is a member of the B complex vitamins and is an essential component for normally functioning epithelium. The compound occurs as a colorless to pale yellow, viscous, hygroscopic liquid that is freely soluble in water, ethanol, and methanol.

Physiological Functions of DL-Panthenol

DL-Panthenol is a provitamin B5 that is converted in the body to pantothenic acid, which is then phosphorylated and incorporated into coenzyme A (CoA). Key physiological roles include:

• Coenzyme A Precursor — Pantothenic acid is the fundamental precursor for the biosynthesis of coenzyme A (CoA) and acyl carrier proteins. These cofactors are indispensable for the TCA cycle, fatty acid synthesis, and the metabolism of carbohydrates and proteins.

• Cellular Energy Metabolism — CoA is required for the conversion of carbohydrates, fats, and proteins into ATP. DL-Panthenol supports mitochondrial energy production through its role in CoA synthesis.

• Skin Barrier and Moisturization — DL-Panthenol is enzymatically converted into pantothenic acid within the skin. This conversion supports hydration and strengthens the skin’s natural barrier function.

• Wound Healing — Dexpanthenol has demonstrated increased fibroblast proliferation and accelerated re-epithelialization in wound healing.

• Anti-Inflammatory and Soothing — Dexpanthenol acts as a topical protectant and moisturizer, and has demonstrated anti-inflammatory properties.

• Cholesterol, Steroid Hormone, and Neurotransmitter Synthesis — Pantothenic acid is essential for the synthesis of cholesterol, steroid hormones, and the neurotransmitter acetylcholine, supporting neurological health and physiological homeostasis.

Mechanisms of Action

Conversion to Pantothenic Acid and CoA

DL-Panthenol is enzymatically oxidized to pantothenic acid. Pantothenic acid is then phosphorylated and incorporated into CoA through a series of enzymatic reactions. CoA is a central metabolic cofactor required for the TCA cycle, fatty acid synthesis, cholesterol synthesis, and the acetylation of proteins and neurotransmitters. Its biological significance is primarily derived from its role as the fundamental precursor for the biosynthesis of coenzyme A (CoA) and acyl carrier proteins.

Skin Barrier Repair and Moisturization

DL-Panthenol penetrates the stratum corneum and is converted to pantothenic acid within skin cells. The presence of panthenol in semisolid formulations significantly enhances skin barrier repair and hydration of the stratum corneum. Dexpanthenol maintains and moisturizes the skin barrier, reduces transepidermal water loss, has antipruritic properties, and increases elasticity in the stratum corneum.

Wound Healing and Anti-Inflammatory Effects

Dermatological effects of topical dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant and moisturizer, and has demonstrated anti-inflammatory properties.

SMVT Bypass and Liposomal Absorption Pathways

Conventional vitamin B5 absorption is mediated by the sodium-dependent multivitamin transporter (SMVT), which is saturable. Liposomal encapsulation offers a biomimetic “Trojan horse” delivery mechanism that protects vitamin B5 from the acidic gastric environment. By utilizing a phospholipid bilayer, this technology enables non-saturable absorption pathways such as passive diffusion, endocytosis, and lymphatic uptake, effectively bypassing the competitive limitations of SMVT and the hepatic first-pass effect.

The Bioavailability Challenge

Despite its essential physiological functions, conventional oral vitamin B5 supplementation faces significant pharmacokinetic challenges. The primary absorption mechanism for pantothenic acid and its derivatives is the sodium-dependent multivitamin transporter (SMVT), which is saturable and exhibits dose-dependent absorption kinetics. At higher doses, SMVT becomes saturated, and absorption efficiency declines, limiting systemic bioavailability. Additionally, pantothenic acid is sensitive to heat and acidic or alkaline conditions, with industrial and domestic processing capable of degrading up to 80% of the vitamin‘s activity. This fragility, coupled with the limited capacity of conventional transport mechanisms, necessitates the development of advanced delivery systems.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. Liposomal formulations represent a promising technological advancement, offering a means to bypass saturable transporters and protect the nutrient from environmental degradation, thereby enhancing systemic bioavailability and therapeutic potential.

Liposomal DL-Panthenol

Liposomal encapsulation of DL-panthenol provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the DL-panthenol molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:

• Achieves 87.84% ± 4.61% encapsulation efficiency for panthenol derivatives

• Bypasses SMVT saturation through non-saturable passive diffusion, endocytosis, and lymphatic uptake

• Protects DL-Panthenol from degradation, increasing its shelf-life and stability in formulations

• Provides enhanced stability and controlled release for DL-Panthenol in nanoparticle-based drug delivery systems

Encapsulation protects DL-Panthenol from degradation, increasing its shelf-life and stability in formulations. The incorporation of DL-Panthenol into nanocarriers such as liposomes offers several advantages, including enhanced stability and controlled release.

Clinical Evidence

Skin Barrier Repair — Clinical Studies

The presence of panthenol in semisolid formulations significantly enhances skin barrier repair and hydration of the stratum corneum. A 28-day randomized study evaluated the efficacy of a topical formulation containing panthenol, niacinamide, and dipotassium glycyrrhizate on skin hydration and barrier function in subjects with xerosis. Panthenol (provitamin B5) exhibits humectant, anti-inflammatory, and epithelial restorative properties. A cream containing linoleic acid, 5% dexpanthenol, and ceramide has been studied in the treatment of atopic dermatitis.

Hair Care Applications

DL-Panthenol is widely used in hair care formulations to enhance hair strength, flexibility, and shine. Panthenol encapsulated in HDS liposomes is able to gradually deliver into the hair, with liposomes up to 15 times greater concentration than other standard liposome products.

Metabolic Management

Pantothenic acid plays a role in the regulation of dyslipidaemia through its role in lipid metabolism and steroid hormone synthesis.

Neuroprotection

Pantothenic acid enhances the synthesis of neurotransmitters like acetylcholine to support neurological health.

Safety and Regulatory

DL-Panthenol is generally well tolerated and is widely used in cosmetic and personal care products. It has no established tolerable upper intake level (UL) due to its low toxicity.

Regulatory Status:

• United States — DL-Panthenol is regulated as a cosmetic ingredient and dietary supplement ingredient. It is listed in the FDA Substances Added to Food database with CAS Registry No. 16485-10-2. USP has established a Reference Standard for Racemic Panthenol (Catalog No. 1494501).

• European Union — DL-Panthenol is authorized as a cosmetic ingredient and is permitted for use in food supplements in EU member states.

• Japan — Panthenol is classified as a third-class OTC drug in Japan.

• Global Standards — DL-Panthenol is monographed in the USP and European Pharmacopoeia as dexpanthenol (D-panthenol). The racemic DL-form is commercially available with ≥99% purity.

Precautions: Individuals with known hypersensitivity to panthenol or pantothenic acid should avoid supplementation. Pregnant or lactating women and children should consult a healthcare professional before use. Rare cases of contact dermatitis have been reported with topical dexpanthenol.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

99$/KG

89$/KG